AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer

Clinical trial NCT01233687 · COMPLETED

Trial details

NCT number: NCT01233687
Sponsor: Ahmad Tarhini
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2011-08-01
Primary completion: 2014-11-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.